ISOENZYME SHIFT FROM GLUCOKINASE TO HEXOKINASE IS NOT AN EARLY BUT A LATE EVENT IN HEPATOCARCINOGENESIS

被引:34
作者
KLIMEK, F
BANNASCH, P
机构
[1] Abteilungfür Cytopathologie, Deutsches Krebsforschungszentrum, D-69120 Heidelberg
关键词
D O I
10.1093/carcin/14.9.1857
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The appearance of hepatocellular adenomas and carcinomas induced in rat liver with N-nitrosomorpholine is preceded by different types of preneoplastic foci consisting of phenotypically altered hepatocytes. The altered cells show changes in the activities of various enzymes including those of carbohydrate metabolism. Glucokinase is a type of hexokinase that is specific for hepatocytes. The enzyme plays a key role in glucose homeostasis in normal liver parenchyma and is replaced in the dedifferentiated hepatocytes of carcinomas by a low K(m) hexokinase. To determine the time course of the shift from glucokinase to this isoenzyme in the development of carcinomas, focal hepatic lesions were dissected from freeze-dried serial tissue sections by the laser-dissection method and studied by microbiochemical tests. In early clear and acidophilic cell foci that excessively stored glycogen (glycogenotic foci) a nearly normal glucokinase activity comparable with that of the surrounding hepatocytes was observed, whereas in the later appearing mixed cell foci a reduction in the activity of this enzyme without a compensatory increase in the hexokinase activity was found. pronounced activity of hexokinase was only measurable in fully developed carcinomas. Since glucokinase is not modified at the post-transcriptional level, a gradual decrease in its mRNA during hepatocarcinogenesis can be assumed. A shift in gene expression from glucokinase to the isoenzyme hexokinase occurs only at the mixed cell foci/carcinoma transition step of the carcinogenic process.
引用
收藏
页码:1857 / 1861
页数:5
相关论文
共 43 条
[1]   HEXOKINASE RECEPTORS - PREFERENTIAL ENZYME BINDING IN NORMAL-CELLS TO NONMITOCHONDRIAL SITES AND IN TRANSFORMED-CELLS TO MITOCHONDRIAL SITES [J].
ARORA, KK ;
PARRY, DM ;
PEDERSEN, PL .
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1992, 24 (01) :47-53
[2]  
BALINSKY D, 1973, CANCER RES, V33, P249
[3]  
BANNASCH P, 1989, Toxicologic Pathology, V17, P617
[4]   HEPATOCELLULAR GLYCOGENOSIS AND RELATED PATTERN OF ENZYMATIC CHANGES DURING HEPATOCARCINOGENESIS [J].
BANNASCH, P ;
HACKER, HJ ;
KLIMEK, F ;
MAYER, D .
ADVANCES IN ENZYME REGULATION, 1984, 22 :97-+
[5]  
Bannasch P., 1990, PATHOLOGY TUMOURS LA, V99, P199
[6]  
BUSTAMANTE E, 1981, J BIOL CHEM, V256, P8699
[7]  
CRISS WE, 1971, CANCER RES, V31, P1523
[8]   LOSS OF ADENYLATE-CYCLASE ACTIVITY IN PRENEOPLASTIC AND NEOPLASTIC LESIONS INDUCED IN RAT-LIVER BY N-NITROSOMORPHOLINE [J].
EHEMANN, V ;
MAYER, D ;
HACKER, HJ ;
BANNASCH, P .
CARCINOGENESIS, 1986, 7 (04) :567-573
[9]  
FARINA FA, 1968, CANCER RES, V28, P1897
[10]   DECREASE IN GLUCOKINASE AND GLUCOSE-6-PHOSPHATASE AND INCREASE IN HEXOKINASE IN PUTATIVE PRENEOPLASTIC LESIONS OF RAT-LIVER [J].
FISCHER, G ;
RUSCHENBURG, I ;
EIGENBRODT, E ;
KATZ, N .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1987, 113 (05) :430-436